<DOC>
	<DOCNO>NCT02377622</DOCNO>
	<brief_summary>The study investigate performance new dialyzer ( Theranova 400 ) contain membrane increase pore sizes . The performance determine removal middle molecule ( different molecular size ) blood compartment . Two different Theranova 400 prototype ( AA BB ) operate hemodialysis mode compare Cordiax Fx-80 dialyzer , operate hemodialysis mode , Cordiax Fx-800 , operate high volume hemodiafiltration mode . Safety event albumin loss dialysate monitor</brief_summary>
	<brief_title>Clinical Performance Comparison 2 THERANOVA 400 Dialyzer Prototypes HD With High-Flux Dialyzers HD hv HDF Mode</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>1 . Patient endstage renal disease ( Chronic kidney disease stage 5D ) 2 . Patient 18 year age old 3 . Patient male female 4 . Patient , female , nonpregnant ; capable become pregnant , use medically acceptable mean contraception participation study 5 .Patient receive HD HDF therapy &gt; 3 month prior study enrollment expect survive least 12 month enrollment . 6 . Patient stable function native fistula 7 . Patient willing comply study requirement therapy entire study treatment period 8 . Patient capable fo provide write informed consent participate study 1 . Patient undergo singleneedle dialysis 2 . Patient know abnormal k/Î» ratio ( less 0.37 , great 3.1 ) 3 . Patient know active infection currently receive antibiotic treatment 4 . Patient known active cancer 5 . Patient known positive serology test human immunodeficiency virus ( HIV ) hepatitis B , C E 6 . Patient know serious hemostasis disorder 7 . Patient known monoclonal gammopathy 8 . Patient known polyclonal gammopathy 9 . Patient unstable condition judge treat physician base medical history , physical examination laboratory test include ( limit ) follow : Myocardial infarction within last 3 month Tachyarrhythmia bradyarrhythmia absoluta Unstable angina pectoris Left ventricular ejection fraction &lt; 30 % Significant pericardial disease 10 . Patient known comorbidity could , opinion Investigator , potentially conflict study purpose procedure 11 . Patient known significant psychiatric disorder mental disability could interfere patient 's ability provide inform consent and/or comply protocol procedures 12 . Patient history noncompliance dialysis prescription , assess Investigator 13 . Patient participate another interventional clinical study past 3 month , currently participate another interventional clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>